How to become a clinical trial volunteer: eligibility criteria and stages of participation
Clinical trials play an essential role in evaluating the safety and efficacy of medicinal products, as well as investigating new diagnostic and therapeutic approaches. Volunteers are an integral part of this process. They may be healthy individuals or patients who agree to participate in a clinical trial.
Participation in a clinical trial requires an informed decision, an understanding of potential risks, and a willingness to comply with the procedures specified in the study protocol. This article explains who can become a clinical trial volunteer, how to find a suitable study, and what rights participants are entitled to.
Who Can Become a Clinical Trial Volunteer?
A clinical trial volunteer is an individual who participates in a medical research study in accordance with an approved study protocol and has received comprehensive information about its objectives, procedures, and potential risks.
Depending on the objectives of the study, participants may include healthy volunteers or patients with specific medical conditions.
Healthy volunteers may participate, for example, in Phase I clinical trials designed to assess the safety, tolerability, and pharmacokinetics of an investigational medicinal product. Pharmacokinetics describes how a drug substance is absorbed, distributed, metabolized, and eliminated by the body.
Patients with specific medical conditions participate in clinical trials designed to evaluate the safety and efficacy of treatments. Such studies help assess the effects of medicinal products, identify adverse reactions, and compare different therapeutic approaches.
Eligibility Criteria for Clinical Trial Participants
There are no universal eligibility criteria for all clinical trials. Requirements are determined by the objectives and design of each individual study.
During the screening and selection process, the following factors are considered:
How to Become a Clinical Trial Volunteer: Key Stages
1. Find a Suitable Clinical Trial
Information about ongoing recruitment can be found on the official websites of clinical research centres and organizations conducting clinical trials.
2. Undergo Preliminary Screening
After an individual expresses interest in participating, clinical research centre staff collect preliminary information, including age, health status, current medications, and other relevant details required to assess potential eligibility.
It is important to provide accurate information about medical conditions, allergies, and all medications being taken, including over-the-counter medicines and dietary supplements. Prescribed treatment must not be discontinued independently for the purpose of qualifying for a clinical trial.
3. Undergo Medical Screening
To determine whether a candidate meets the study eligibility criteria, a screening process is conducted. This involves a series of preliminary medical assessments specified in the study protocol.
Depending on the study, screening may include medical history collection, a physical examination, blood pressure measurement, blood and urine tests, electrocardiography (ECG), and other diagnostic procedures.
The results are evaluated by the investigator. If the candidate meets the inclusion criteria and has no exclusion criteria, they may be enrolled in the clinical trial.
4. Provide Informed Consent
Before any study-specific procedures are performed, prospective participants must receive all the information necessary to make an informed decision about participation. This process is known as obtaining informed consent and represents one of the fundamental ethical principles of clinical research.
The Informed Consent Form (ICF) generally contains information about:
5. Participate in the Clinical Trial
Once enrolled, participants undergo the procedures specified in the study protocol. These may include administration of the investigational medicinal product, medical examinations, laboratory testing, and scheduled visits to the clinical research centre.
Participants are expected to follow the agreed visit schedule, comply with the instructions provided by the study team, and promptly report any changes in their health status, adverse events, or the initiation of new medications.
What Rights Do Clinical Trial Volunteers Have?
Protecting the rights, safety, and well-being of clinical trial participants is one of the fundamental principles of Good Clinical Practice (GCP).
Clinical trial volunteers have the following rights:
Clinical trials are conducted in accordance with established ethical and regulatory requirements. However, this does not mean that participation is entirely risk-free.
Potential adverse reactions depend on the investigational medicinal product, medical intervention, the participant's health status, and the specific study protocol. Even routine procedures, such as blood sampling, may cause pain, bruising, or dizziness.
To protect participants, clinical trials incorporate preliminary risk assessments, eligibility screening, medical supervision, and adverse event reporting and documentation. Where required, studies are subject to review by an Ethics Committee (EC) or Institutional Review Board (IRB), as well as the relevant regulatory procedures.
The international ICH E6(R3) Guideline for Good Clinical Practice establishes principles for protecting clinical trial participants and ensuring the quality of clinical trials. Nevertheless, compliance with GCP cannot guarantee the complete absence of adverse reactions.
Before deciding to participate, prospective volunteers should understand the known risks, how medical monitoring is organized, and whom to contact if their health deteriorates.
Common Misconceptions About Clinical Trial Participation
Myth 1. Only completely healthy individuals can participate.
This is not true. Clinical trials recruit both healthy volunteers and patients with specific medical conditions. Eligibility requirements depend on the objectives of the study.
Myth 2. Participation guarantees access to effective treatment.
This is incorrect. An investigational medicinal product may prove ineffective or cause adverse reactions. Depending on the study design, participants may receive the investigational product, a comparator product, standard treatment, or a placebo, where ethically and medically appropriate.
Myth 3. Once informed consent has been signed, participants cannot withdraw.
This is false. Volunteers have the right to withdraw their informed consent and discontinue participation. They are encouraged to discuss the safe discontinuation of study procedures with the research team.
Myth 4. Passing screening guarantees enrolment in the clinical trial.
This is not the case. The final enrolment decision is based on all eligibility criteria specified in the study protocol and the results of the medical assessments.
An individual can become a clinical trial volunteer if they meet the eligibility criteria of a specific study and make an informed decision to participate. The process involves finding a suitable clinical trial, undergoing preliminary screening and medical assessments, reviewing the study information, and providing informed consent.
Clinical trials generate scientific evidence essential for the development and evaluation of new approaches to disease prevention, diagnosis, and treatment. At the same time, participation requires a responsible attitude towards one's health, an understanding of potential risks, and a willingness to comply with the study protocol.
The fundamental principle is that the decision to participate always remains with the individual. Every volunteer has the right to receive the necessary information, ask questions, and decline or withdraw from participation if the proposed conditions are not suitable.
Participation in a clinical trial requires an informed decision, an understanding of potential risks, and a willingness to comply with the procedures specified in the study protocol. This article explains who can become a clinical trial volunteer, how to find a suitable study, and what rights participants are entitled to.
Who Can Become a Clinical Trial Volunteer?
A clinical trial volunteer is an individual who participates in a medical research study in accordance with an approved study protocol and has received comprehensive information about its objectives, procedures, and potential risks.
Depending on the objectives of the study, participants may include healthy volunteers or patients with specific medical conditions.
Healthy volunteers may participate, for example, in Phase I clinical trials designed to assess the safety, tolerability, and pharmacokinetics of an investigational medicinal product. Pharmacokinetics describes how a drug substance is absorbed, distributed, metabolized, and eliminated by the body.
Patients with specific medical conditions participate in clinical trials designed to evaluate the safety and efficacy of treatments. Such studies help assess the effects of medicinal products, identify adverse reactions, and compare different therapeutic approaches.
Eligibility Criteria for Clinical Trial Participants
There are no universal eligibility criteria for all clinical trials. Requirements are determined by the objectives and design of each individual study.
During the screening and selection process, the following factors are considered:
- Age and overall health status;
- Presence or absence of specific medical conditions;
- Medical history and history of allergic reactions;
- Current medications and concomitant treatments;
- Results of laboratory tests and diagnostic procedures;
- Ability to comply with the visit schedule and study protocol requirements.
How to Become a Clinical Trial Volunteer: Key Stages
1. Find a Suitable Clinical Trial
Information about ongoing recruitment can be found on the official websites of clinical research centres and organizations conducting clinical trials.
2. Undergo Preliminary Screening
After an individual expresses interest in participating, clinical research centre staff collect preliminary information, including age, health status, current medications, and other relevant details required to assess potential eligibility.
It is important to provide accurate information about medical conditions, allergies, and all medications being taken, including over-the-counter medicines and dietary supplements. Prescribed treatment must not be discontinued independently for the purpose of qualifying for a clinical trial.
3. Undergo Medical Screening
To determine whether a candidate meets the study eligibility criteria, a screening process is conducted. This involves a series of preliminary medical assessments specified in the study protocol.
Depending on the study, screening may include medical history collection, a physical examination, blood pressure measurement, blood and urine tests, electrocardiography (ECG), and other diagnostic procedures.
The results are evaluated by the investigator. If the candidate meets the inclusion criteria and has no exclusion criteria, they may be enrolled in the clinical trial.
4. Provide Informed Consent
Before any study-specific procedures are performed, prospective participants must receive all the information necessary to make an informed decision about participation. This process is known as obtaining informed consent and represents one of the fundamental ethical principles of clinical research.
The Informed Consent Form (ICF) generally contains information about:
- The objectives and duration of the clinical trial;
- Study procedures and participation requirements;
- Known risks and potential inconveniences;
- Anticipated benefits and limitations of the expected therapeutic effect;
- Measures for protecting the confidentiality of personal data;
- Reimbursement of expenses or compensation, where applicable;
- Contact details for reporting concerns or asking questions about participation and safety.
5. Participate in the Clinical Trial
Once enrolled, participants undergo the procedures specified in the study protocol. These may include administration of the investigational medicinal product, medical examinations, laboratory testing, and scheduled visits to the clinical research centre.
Participants are expected to follow the agreed visit schedule, comply with the instructions provided by the study team, and promptly report any changes in their health status, adverse events, or the initiation of new medications.
What Rights Do Clinical Trial Volunteers Have?
Protecting the rights, safety, and well-being of clinical trial participants is one of the fundamental principles of Good Clinical Practice (GCP).
Clinical trial volunteers have the following rights:
- The right to receive comprehensive information. Participants must understand the objectives of the study, the procedures involved, and the known risks.
- The right to make an independent decision. Individuals have the right to decide whether to participate without coercion or undue restrictions on their access to appropriate medical care.
- The right to withdraw from the study. Participants may withdraw their informed consent and discontinue participation at any time. It is advisable to discuss the safe discontinuation of study procedures and any necessary follow-up with the investigator.
- The right to data privacy and confidentiality. Information relating to participants must be processed and protected in accordance with applicable data protection and confidentiality requirements.
- The right to report adverse events. Participants should notify the study team of any new symptoms or changes in their health. In the event of severe or emergency symptoms, they should seek immediate medical attention.
Clinical trials are conducted in accordance with established ethical and regulatory requirements. However, this does not mean that participation is entirely risk-free.
Potential adverse reactions depend on the investigational medicinal product, medical intervention, the participant's health status, and the specific study protocol. Even routine procedures, such as blood sampling, may cause pain, bruising, or dizziness.
To protect participants, clinical trials incorporate preliminary risk assessments, eligibility screening, medical supervision, and adverse event reporting and documentation. Where required, studies are subject to review by an Ethics Committee (EC) or Institutional Review Board (IRB), as well as the relevant regulatory procedures.
The international ICH E6(R3) Guideline for Good Clinical Practice establishes principles for protecting clinical trial participants and ensuring the quality of clinical trials. Nevertheless, compliance with GCP cannot guarantee the complete absence of adverse reactions.
Before deciding to participate, prospective volunteers should understand the known risks, how medical monitoring is organized, and whom to contact if their health deteriorates.
Common Misconceptions About Clinical Trial Participation
Myth 1. Only completely healthy individuals can participate.
This is not true. Clinical trials recruit both healthy volunteers and patients with specific medical conditions. Eligibility requirements depend on the objectives of the study.
Myth 2. Participation guarantees access to effective treatment.
This is incorrect. An investigational medicinal product may prove ineffective or cause adverse reactions. Depending on the study design, participants may receive the investigational product, a comparator product, standard treatment, or a placebo, where ethically and medically appropriate.
Myth 3. Once informed consent has been signed, participants cannot withdraw.
This is false. Volunteers have the right to withdraw their informed consent and discontinue participation. They are encouraged to discuss the safe discontinuation of study procedures with the research team.
Myth 4. Passing screening guarantees enrolment in the clinical trial.
This is not the case. The final enrolment decision is based on all eligibility criteria specified in the study protocol and the results of the medical assessments.
An individual can become a clinical trial volunteer if they meet the eligibility criteria of a specific study and make an informed decision to participate. The process involves finding a suitable clinical trial, undergoing preliminary screening and medical assessments, reviewing the study information, and providing informed consent.
Clinical trials generate scientific evidence essential for the development and evaluation of new approaches to disease prevention, diagnosis, and treatment. At the same time, participation requires a responsible attitude towards one's health, an understanding of potential risks, and a willingness to comply with the study protocol.
The fundamental principle is that the decision to participate always remains with the individual. Every volunteer has the right to receive the necessary information, ask questions, and decline or withdraw from participation if the proposed conditions are not suitable.